ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial
Public ClinicalTrials.gov record NCT01913483. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study is to test whether anticoagulation with bivalirudin results in fewer major bleeding complications compared with unfractionated heparin (UFH) in participants undergoing peripheral endovascular interventions (PEI). The secondary objective is to test whether there were potential benefits from bivalirudin therapy on other clinically important events such as death, myocardial infarction (MI), stroke and/or transient ischemic attack (TIA), amputation, unplanned repeat revascularization (URV), and minor bleeding, as well as potential economic benefits that may result from improved clinical outcomes.
Study identification
- NCT ID
- NCT01913483
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 732 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 24, 2013 (Actual)
- Primary completion
- Mar 16, 2016 (Actual)
- Completion
- Mar 16, 2016 (Actual)
- Last update posted
- May 30, 2017
2013 – 2016
United States locations
- U.S. sites
- 39
- U.S. states
- 22
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tri-Lakes Research | Hot Springs | Arkansas | 71901 | — |
| Stanford Hospital and Clinics | Stanford | California | 94305-5407 | — |
| Clearwater Cardiovascular and Interventional Consultants | Clearwater | Florida | 33756 | — |
| Florida Research Network | Gainesville | Florida | 32605 | — |
| The Cardiac and Vascular Institute | Gainesville | Florida | 32605 | — |
| Baptist Cardiac & Vascular Institute | Miami | Florida | 33176 | — |
| Florida Hospital | Orlando | Florida | 32803 | — |
| Peoria Radiology Research & Education Foundation | Peoria | Illinois | 61637 | — |
| Midwest Cardiovascular Research Foundation | Davenport | Iowa | 52803 | — |
| Kentucky Heart Foundation - King's Daughters Medical Center | Ashland | Kentucky | 41101 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| VA Boston Healthcare System | Boston | Massachusetts | 02132 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Cape Cod Research Institute | Hyannis | Massachusetts | 02601 | — |
| Michigan Heart | Ypsilanti | Michigan | 48197 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Deborah Heart and Lung Center | Browns Mills | New Jersey | 08015 | — |
| Holy Name Medical Center | Teaneck | New Jersey | 07666 | — |
| New Mexico Heart Institute | Albuquerque | New Mexico | 87102 | — |
| Weill Cornell Medical College | New York | New York | 10021 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Stony Brook Medicine | Stony Brook | New York | 11794 | — |
| Novant Health Heart and Vascular Institute | Charlotte | North Carolina | 28204 | — |
| LeBauer Cardiovascular Research Foundation | Greensboro | North Carolina | 27401 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Jobst Vascular Institute | Toledo | Ohio | 43606 | — |
| Integris - Baptist Medical Center | Oklahoma City | Oklahoma | 73112 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
| AnMed Health | Anderson | South Carolina | 29621 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Texas Tech University Health Science Center | Lubbock | Texas | 79430 | — |
| Scott and White Hospital | Temple | Texas | 76508 | — |
| Alpine Research | Ogden | Utah | 84403 | — |
| INOVA Alexandria Hospital | Alexandria | Virginia | 22304 | — |
| University of Virginia Health System | Charlottesville | Virginia | 22908 | — |
| Swedish Medical Center | Seattle | Washington | 98122 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01913483, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 30, 2017 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01913483 live on ClinicalTrials.gov.